• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Raptor Pharmaceuticals Corp. (RPTP)

    -NasdaqGM
    9.04 Down 0.31(3.32%) Jan 30, 4:00PM EST
    |After Hours : 9.65 Up 0.61 (6.75%) Jan 30, 6:57PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Aug 31, 2012
    Total Revenue 16,872   -   -  
    Cost of Revenue1,653   -   -  
    Gross Profit 15,219   -   -  
    Operating Expenses
    Research Development29,177  8,963  21,443  
    Selling General and Administrative37,948  8,971  14,723  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (51,906) (17,934) (36,166)
    Income from Continuing Operations
    Total Other Income/Expenses Net(10,679)(1,275)(2,475)
    Earnings Before Interest And Taxes(62,585)(19,209)(38,641)
    Interest Expense6,832  83  3  
    Income Before Tax(69,417)(19,292)(38,644)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(69,417)(19,292)(38,644)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (69,417) (19,292) (38,644)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (69,417) (19,292) (38,644)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.